Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Recombinant human parathyroid hormone (1-34) vs alendronate in postmenopausal osteoporosis
CTR20140349Phase 3Completed
- Sponsor
- Shanghai Zhongke Shenglongda Biotechnology
- Start
- Jul 2014
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 3 trial of teriparatide in osteoporosis, sponsored by Shanghai Zhongke Shenglongda Biotechnology. Started Jul 2014; status: completed.
02
Drugs
teriparatide
03
Conditions
osteoporosis
Beyond the preview
Go deeper on CTR20140349.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20140349.